ESC 365 - Five year all-cause mortality and dual anti-platelet therapy after transcatheter aortic valve implantation

ESC Premium Access

Five year all-cause mortality and dual anti-platelet therapy after transcatheter aortic valve implantation

Session: Poster session 6 - Valvular disease

Topic: Surgery and intervention in valve disease

Speaker: Professor E. Vavouranakis (Athens, GR)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Professor Emmanouil Vavouranakis

National & Kapodistrian University of Athens Medical School, Athens (Greece)

1 presentation

1 follower

26 more presentations in this session

The obesity paradox in patients undergoing transcatheter aortic valve implantation

Speaker: Mr R. Hoellriegel (Dresden, DE)

Lower trans-aortic flow rate is associated with increased cardiovascular and all-cause mortality in aortic valve stenosis

Speaker: Doctor S. Saeed (Bergen, NO)

High sensitivity troponin T plasma levels predict postoperative survival in patients with severe aortic stenosis undergoing valve implantation

Speaker: Doctor F. Barbieri (Berlin, DE)

Quality of life in high risk patients with severe aortic stenosis treated either with AVR or TAVI

Speaker: Doctor C. Ciuca (Bologna, IT)

Higher left ventricular mass-stress-heart rate product is associated with increased cardiovascular morbidity and mortality in aortic valve stenosis

Speaker: Professor E. Gerdts (Bergen, NO)

Access the full session

Poster session 6 - Valvular disease

Speakers: Professor E. Vavouranakis, Mr R. Hoellriegel, Doctor S. Saeed, Doctor F. Barbieri, Doctor C. Ciuca...

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources